Dizziness

BOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024 Grant Program Supporting Women Entrepreneurs

Retrieved on: 
Wednesday, February 21, 2024

IRVINE, Calif., Feb. 21, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that applications are open for the 2024 BOTOX® Cosmetic grant program supporting women entrepreneurs. BOTOX® Cosmetic partnered with IFundWomen to launch the program in 2023, and in the second year, will award a new group of 20 women entrepreneurs each with $25,000 grants to fund and grow their businesses. Additionally, BOTOX® Cosmetic continues to support these businesses through mentorship, coaching, crowdfunding, and community.

Key Points: 
  • FOR THE SECOND YEAR, BOTOX® COSMETIC WILL HELP WOMEN ENTREPRENEURS CLOSE THE CONFIDENCE GAP THROUGH FUNDING, MENTORSHIP, COACHING, AND COMMUNITY
    IRVINE, Calif., Feb. 21, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that applications are open for the 2024 BOTOX® Cosmetic grant program supporting women entrepreneurs.
  • We are grateful to learn from them and thrilled to continue this program into a second year with a new cohort of extraordinary women entrepreneurs."
  • I am forever grateful to this program for connecting me to a group of women entrepreneurs who together are helping to bridge the Confidence Gap.
  • Starting today, women entrepreneurs across the country can apply for the BOTOX® Cosmetic x IFundWomen grant at www.botoxcosmetic.com/realimpact for the chance to be one of 20 recipients.

Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Retrieved on: 
Friday, February 16, 2024

Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Key Points: 


Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Spice: the ‘zombie drug’ being found in some vape liquids

Retrieved on: 
Thursday, February 15, 2024

This incident is only the latest in what appears to be a growing problem in the UK with unregulated vape liquids, especially those marketed as containing THC or cannabis.

Key Points: 
  • This incident is only the latest in what appears to be a growing problem in the UK with unregulated vape liquids, especially those marketed as containing THC or cannabis.
  • This is why it’s so important for users to think carefully about what vape products they use.

What is spice?

  • While these lab-made drugs are designed to mimic the effects of cannabis, they tend to be far more unpredictable and harmful.
  • There’s currently no data on how these drugs are manufactured in clandestine laboratories thought to be located in China and India.
  • But we do have some idea of how spice may be synthesised, based on academic experiments that have been published in peer-reviewed journals.

What makes spice harmful?

  • Studies have shown that the compounds contained in spice act on both types of cannabinoid receptors that the body has.
  • Those who use spice repeatedly can develop a tolerance to it, requiring more to achieve the desired effect – ultimately putting them at higher risk of harm.

How does spice affect users?


Synthetic cannabinoid receptor agonists were initially explored as experimental drugs to alleviate suffering related to a variety of conditions – including pain, anorexia, muscle spasms and glaucoma.

  • Many people use spice in the hopes of experiencing effects similar to those caused by cannabis.
  • It isn’t possible to predict who will suffer which of these side effects, but all spice users are at risk.

Is spice a growing problem?

  • One investigation even found that nearly half of male prison deaths that happened between 2015-2020 in England and Wales were due to Spice.
  • There is also an increasing number of reports in the press of vape liquids being laced with spice – leading public health authorities to issue warnings.
  • There are now calls to make young people more aware of the dangers of spice and using certain types of vape liquids.


Michael Cole receives funding and "in kind" support from the European Union and a number police forces and forensic science organisations around the world to carry out research.

Starton Therapeutics Announces Opening of Second Clinical Site for STAR-LLD Phase 1b Trial in Multiple Myeloma and Provides Study Update

Retrieved on: 
Wednesday, February 14, 2024

The ongoing study evaluates the safety, pharmacokinetics, and efficacy of continuous subcutaneous administration of low-dose lenalidomide (STAR-LLD) in conjunction with dexamethasone and bortezomib (Velcade®).

Key Points: 
  • The ongoing study evaluates the safety, pharmacokinetics, and efficacy of continuous subcutaneous administration of low-dose lenalidomide (STAR-LLD) in conjunction with dexamethasone and bortezomib (Velcade®).
  • Remarkably, the trial is progressing ahead of schedule and with the addition of RMOC is now projected to conclude enrollment by Q1/2024.
  • I’m excited about the potential opportunity STAR-LLD can bring to multiple myeloma patients.”
    Earlier last month, Starton disclosed preliminary trial findings regarding the safety and efficacy of STAR-LLD for multiple myeloma.
  • Notably, no hematologic toxicities greater than Grade 1 have been observed following up to 3 cycles of treatment thus far.

FDA Approves First Medication to Treat Severe Frostbite

Retrieved on: 
Wednesday, February 14, 2024

SILVER SPRING, Md., Feb. 14, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.

Key Points: 
  • SILVER SPRING, Md., Feb. 14, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.
  • Frostbite can occur in several stages, ranging from mild frostbite that does not require medical intervention and does not cause permanent skin damage, to severe frostbite when both the skin and underlying tissue are frozen and blood flow is stopped, sometimes requiring amputation.
  • Iloprost's efficacy in treating severe frostbite was primarily established in an open-label, controlled trial that randomized 47 adults with severe frostbite, who all received aspirin by vein and standard of care, into one of three treatment groups.
  • The two other groups received other medications that are unapproved for frostbite, given with iloprost (Group 2) or without iloprost (Group 3).

Romance isn’t always rosy, sometimes it’s sickening – lovesickness, erotomania and death by heartbreak explained

Retrieved on: 
Tuesday, February 13, 2024

All you need is love.

Key Points: 
  • All you need is love.
  • It’s better to have loved and lost than never to have loved at all.
  • But is love all pink hearts, roses and teddy bears – or is there a darker side?

Pathological Love

  • Love can hurt.
  • Ian McEwan framed a pathological form of affection, leading to obsession in his 1997 novel “Enduring Love”.
  • They appear even in the words of Hippocrates, described as a form of unrequited love.
  • The condition has seen a renaissance, over the past three centuries, shifting from unanswered love to sex addiction, to its current standing of delusions of love.

I love Paris in the springtime

  • Love, or perceptions of love for material objects or places rather than individuals might also be enough to trigger psychiatric illness.
  • Stendhal was not a psychiatrist, but a writer, who found himself overcome by the beauty of Florence when travelling there in 1817.
  • For others, unfortunately not – leading to a condition known as Paris Syndrome.

Too many broken hearts in the world

  • The term broken heart syndrome applies to a genuine cardiac condition – Takotsubo cardiomyopathy.
  • The underlying cause of broken heart syndrome?
  • The raised levels of adrenaline have been proposed as an underlying cause of broken heart syndrome – a link between heart and mind – though more research is required to tell for sure.


Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Why it’s a bad idea to mix alcohol with some medications

Retrieved on: 
Monday, February 12, 2024

But you may not be aware that mixing certain medicines with alcohol can increase the effects and put you at risk.

Key Points: 
  • But you may not be aware that mixing certain medicines with alcohol can increase the effects and put you at risk.
  • When you mix alcohol with medicines, whether prescription or over-the-counter, the medicines can increase the effects of the alcohol or the alcohol can increase the side-effects of the drug.
  • This is because there is less water in their bodies that can mix with the alcohol.
  • If you do want to drink alcohol while being on medication, discuss it with your doctor or pharmacist first.

Why are so many Australians taking antidepressants?

Retrieved on: 
Thursday, February 8, 2024

Around one in seven Australians take antidepressants; more than 3.5 million of us had them dispensed in 2021–22.

Key Points: 
  • Around one in seven Australians take antidepressants; more than 3.5 million of us had them dispensed in 2021–22.
  • Guidelines mostly recommend antidepressants for more severe depression and anxiety but not as first-line treatment for less severe depression.
  • So why are so many Australians taking antidepressants and why are prescriptions rising?

Enter the antidepressant ‘blockbusters’

  • In the 1990s, pharmaceutical companies heavily promoted new selective serotonin reuptake inhibitors (SSRI) antidepressants, including Prozac (fluoxetine), Zoloft (sertraline) and Lexapro (escitalopram).
  • These drugs were thought to be less dangerous in overdoses and seemed to have fewer side effects than the tricyclic antidepressants they replaced.
  • Pharmaceutical companies marketed SSRIs energetically and often exaggerated their benefits, including by paying “key opinion leaders” – high-status clinicians to promote them.

Why are antidepressants prescribed?

  • GPs also prescribe antidepressants to patients experiencing distress but who don’t have a psychiatric diagnosis.
  • Another, who cried when informed she had breast cancer, was immediately offered a prescription for antidepressants.
  • Most patients believe antidepressants restore a chemical imbalance that underpins depression.
  • Antidepressants are emotional (and sexual) numbing agents – sometimes sedating, sometimes energising.
  • Around half of users have impaired sexual function and for some, this sexual dysfunction persists after stopping antidepressants.

How long do people take antidepressants?

  • Around half of patients who start antidepressants don’t like them and stop within weeks.
  • Of those who do take them for months, many continue to use them indefinitely, often for many years.
  • Read more:
    Antidepressants can cause withdrawal symptoms – here’s what you need to know

We need to adjust how we view mental distress

  • Overprescribing antidepressants is a symptom of our lack of attention to the social determinants of mental health.
  • GPs also need to ensure they discuss with their patients the potential adverse effects of antidepressants, and when and how to safely stop them.
  • But the fundamental problem is social and can only be properly addressed by meaningfully addressing inequality and changing community attitudes to distress.


Jon Jureidini receives research funding from MMRF. He is affiliated with Critical Psychiatry Network Australasia.

VARON Unveils the VP-2 Portable Oxygen Concentrator Skier's Bundle: Revolutionizing the High-Altitude Skiing Experience with Cutting-edge Technology

Retrieved on: 
Wednesday, February 7, 2024

This product marks a significant advancement in oxygen technology and offers a new level of support for those exploring the majestic, yet challenging, high-altitude terrains, redefining the high-altitude skiing experience.

Key Points: 
  • This product marks a significant advancement in oxygen technology and offers a new level of support for those exploring the majestic, yet challenging, high-altitude terrains, redefining the high-altitude skiing experience.
  • VARON's VP-2 Portable Oxygen Concentrator is the perfect choice to address this challenge, enhancing oxygen intake in environments where natural air density falls short.
  • Using VP-2, skiers can fully immerse themselves in the thrill of the slopes without the limitations imposed by the altitude.
  • With the VP-2 Portable Oxygen Concentrator Skier's Bundle, VARON is setting a new standard in high-altitude skiing experience.

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Retrieved on: 
Tuesday, February 6, 2024

In one market development, members of Vivos’ nationwide network of over 1,850 trained providers are actively treating current and former ResMed and Philips Respironics’ CPAP device users with Vivos CARE oral medical devices.

Key Points: 
  • In one market development, members of Vivos’ nationwide network of over 1,850 trained providers are actively treating current and former ResMed and Philips Respironics’ CPAP device users with Vivos CARE oral medical devices.
  • Vivos-trained providers currently treat failed HGNS cases using Vivos CARE oral medical devices and treatment plans.
  • Vivos believes most OSA patients seeking HGNS implants have high-moderate or severe OSA, leaving Vivos CARE oral medical devices as their only approved oral appliance therapy option.
  • We believe all of these factors create very significant revenue opportunities for us as we continue to spread the word about our product offerings.”